The FDA is looking at shifting to a brief summary format more like that of the “Drug Facts” design used for OTC products, based on a study showing that it led to higher risk comprehension. The ...
While this specification was developed to support the immediate needs of the security automation and the continuous monitoring communities, it is expected that this specification will be valuable to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results